- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05213520
Effect of a 4-week Alternate Day Intermittent Energy Restriction Intervention vs Reduced (AltER2022)
Effect of a Novel Alternate Day Intermittent Energy Restriction Intervention vs. Standard Reduced Calorie Diet on Body Weight, Body Composition, and Resting Metabolic Rate in College Students With Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study proposes to investigate the scope and benefits of a novel, hybrid alternate day fasting protocol tailored to the college student lifestyle. This protocol - Alternate Day Intermittent Energy Restriction (AltER) is novel because it proposes to modify the standard ADF regime by increasing energy intake to 40% of calorie needs on fasting days. While this may not be as restrictive as other protocols, it still can help create a significant energy deficit. Additionally, it will provide flexibility by allowing for two consecutive fast days if the individual chooses to. While most dietary interventions can achieve significant weight loss in this short duration we expect that this approach tailored to college lifestyle will be superior to typical dietary restriction.
Subjects will be asked to attend two approximately 90-minute assessment visits (4 weeks apart) at the NMHI facility They will have their height weight and blood pressure measured, fill out questionnaires (attached), and have body composition (BodPod) and resting metabolic rate (Metabolic Cart) measured.
At completion of visit one they are randomly assigned to one of two Diet protocols designed to reduce calories and help them to safely lose weight They will also be asked to respond to a brief (3 questions) email survey weekly.
The AltER diet alternate between full calorie (no restriction) eating days with eating 40% of your daily caloric requirement on the other day. There will be occasional exceptions allowed with maximum of two 40% days in a row (followed by two full days) based on personal schedule with prior PI approval. The RCD will require a reduction of 500-1000 calories below daily energy requirement. The intervention or control diet will be followed for a duration of 4 weeks at the end of which the participants will come in for visit 2 which will follow a similar format like visit 1.
General Aim
To determine the effect of a novel, alternate day intermittent calorie restriction intervention on body weight, fat mass and resting metabolic rate of college students with obesity as compared to a standard reduced calorie diet 3.2.1. Specific Aim 1: To determine the effect of a novel, alternate day intermittent calorie restriction intervention on body weight of college students with obesity as compared to a standard reduced calorie diet.
3.2.1. Specific Aim 2: To determine the effect of a novel, alternate day intermittent calorie restriction intervention on fat mass of college students with obesity as compared to a standard reduced calorie diet.
3.2.2. Specific Aim 3: To determine the effect of a novel, alternate day intermittent calorie restriction intervention on resting metabolic rate of college students with obesity as compared to a standard reduced calorie diet.
3.2.2. Specific Aim 4: To explore the relationships of stress, sleep physical activity and weight history/demographic variables in relation to primary outcomes of interest.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79409
- Texas Tech University - Department of Nutritional Sciences
-
Lubbock, Texas, United States, 79410
- Nutrition and Metabolic Health Initiative
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18 -25 years
- Enrolled as full-time college students
- Have a BMI ≥ 30
- Willing and able to give informed consent
- Willing to follow either dietary intervention assigned to them upon randomization.
- Able to come in for all assessment visits.
Exclusion Criteria:
- Participants who are currently diagnosed with diabetes mellitus, cardiovascular disease, liver or kidney disease, cancer
- Current severe psychiatric illnesses (e.g. psychosis, schizophrenia, bipolar disorders, depression
- Current suicidal ideation, and recent or past suicide attempts
- History of psychiatric hospitalization (past year).
- History of diagnosed eating disorders such as bulimia nervosa, anorexia nervosa and severe binge eating disorder.
- History of diagnosed substance abuse or alcohol abuse.
- Currently on any weight loss diet.
- Having lost in the past 3 months 10% or more of body weight.
- Unwilling or unable to give informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Alternate Day Intermittent Energy Restriction
Participants assigned to this diet will be asked to alternate between full calorie (no restriction) eating days with eating 40% of their daily caloric requirement on the other day.
For example, if their requirement is 2000 calories they would eat 800 calories one day and as much as you want on the other day and repeat every two days.
There will be occasional exceptions allowed with maximum of two 40% days in a row (followed by two full days) based on personal schedule with prior approval.
They will follow this for 4 weeks.
|
It is a dietary intervention designed to alternate between full energy consumption on one day and 40% of daily energy requirement on the following day.
|
|
Active Comparator: Reduced Calorie Diet
Participants assigned to this diet will be asked to restrict calorie intake by 500-1000 calories below their daily energy requirement every day.
They will follow this for 4 weeks.
|
It is a dietary intervention designed to reduce daily calorie intake by 500-1000 kcal below an individual's daily calorie needs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Weight
Time Frame: 4 weeks
|
Change in body weight in pounds.
|
4 weeks
|
|
Fat Mass
Time Frame: 4 weeks
|
Change in fat mass in pounds as measured by body composition assessment.
|
4 weeks
|
|
Resting Metabolic Rate
Time Frame: 4 week
|
Change in resting metabolic rate as measured by indirect calorimetry.
|
4 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Martin Binks, Ph.D., Texas Tech University- Department of Nutritional Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2021-1092
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Alternate Day Intermittent Energy Restriction
-
King's College LondonMedical Research Council; Mars, Inc.CompletedAging | Cognitive DeclineUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompleted
-
Oslo University HospitalCompletedObesity | Dietary Modification | CVDNorway
-
Universidade do PortoUniversity of LisbonActive, not recruitingObesity | Weight LossPortugal
-
University of LeedsUniversity of Illinois at ChicagoCompleted
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI); Pennington Biomedical Research...CompletedObesity | Weight Loss | Coronary Heart DiseaseUnited States
-
King's College LondonLighterLife (UK) LtdCompletedObesity, AbdominalUnited Kingdom
-
University of NottinghamCompletedWeight LossUnited Kingdom
-
Ohio State UniversityNational Psoriasis FoundationCompletedPsoriasis | Psoriatic ArthritisUnited States
-
Universiti Sains MalaysiaCompletedNon-Alcoholic Fatty Liver Disease